B2M and colorectal carcinoma: We analyzed B2M in incident and prevalent CRCs and found a B2M mutation prevalence of 20.8% (5/24) in incident CRC, which was similar to the B2M mutation prevalence of prevalent CRC (13/54, 24.1%; p = 1.0).